Specialty Nutrients
Hi-Tech Claims FDA Backed Off Synthetic Botanical Position in DMAA Litigation
LitigationHi-Tech Claims FDA Backed Off Synthetic Botanical Position in DMAA LitigationHi-Tech Claims FDA Backed Off Synthetic Botanical Position in DMAA Litigation
What this means for the greater industry is unclear, but the DMAA fight might hinge on its presence and metabolic pathway in the plant.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.